Subway has been placed in a difficult situation after The New York Times released its lab test report on the sandwich chain’s Subway tuna product. It was said that the publication initiated the lab test due to the company’s lawsuits.
As per Fox Business, a 60-inch Subway tuna sandwich was tested at a lab and the result stated that “no amplifiable tuna DNA was present” in the food item. This means that the lab analysis failed to find or identify any tuna DNA in the food.
The tuna sandwich test
Subway has been wrapped up in some lawsuits regarding its sandwiches. Customers have different complaints but there was a customer who said that the tuna in the tuna sandwich is not the fish that everyone knows. In simpler words, it was claimed that the tuna could not be real tuna meat.
In any case, in The New York Times report, it said that it brought sandwiches from three different Subway outlets around Los Angeles for testing. This was done after a customer filed a lawsuit earlier this year, claiming the tuna fish is made from "a mixture of various concoctions."
For the lab test, the tuna was frozen and was brought to the lab. It was mentioned that a PCR test was done to determine if the tuna from Subway’s sandwiches is one of the five tuna species. However, the lab could not identify which species because it did not find tuna DNA at all.
It is fake tuna?
Then again, it cannot be assumed that Subway is using fake tuna in its sandwiches. In fact, this may not be the truth because it was explained that there are two possible reasons why the tuna DNA was not detected.
"One, it’s so heavily processed that whatever we could pull out, we couldn’t make an identification,” the lab’s spokesman told The New York Times. “Or we got some and there’s just nothing there that’s tuna."
On the other hand, some experts said that it is also possible that the DNA disappeared when tuna was cooked. Because in this process, the protein breaks down and this makes it difficult to spot the DNA.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anta Sports Expands Global Footprint With Strategic Puma Stake
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



